Here are 100 books that Creating Cures fans have personally recommended if you like
Creating Cures.
Shepherd is a community of 12,000+ authors and super readers sharing their favorite books with the world.
I am the former president of Pfizer Global Research, where I led research groups around the globe in finding new medicines to treat cancer, addiction, AIDS, immunological diseases, and pain. After retiring from Pfizer, I have been closely involved with biotech companies that also are seeking breakthrough drugs. This industry is a crucial part of the healthcare ecosystem, as evidenced by the remarkable response and, ultimately, the crushing of the COVID-19 pandemic. Yet, it is not just underappreciated but is treated with scorn by many. This booklist provides sources from which the reader can gain a full understanding of the value of the biopharmaceutical industry, the challenges it faces, and its importance to the world’s health.
Legislators and healthcare insurers are seeking ways to slash healthcare costs, often focusing on cutting the costs of medicines through schemes like price controls. Yet, drugs make up only about 13 percent of the money paid on healthcare. This book does a great job of explaining what is behind the pricing of new drugs but, more importantly, shows that all life-saving drugs eventually become low-cost generics – truly a Great American Drug Deal.
This book scrutinizes all players in the healthcare industry and offers new ideas for cost-saving measures, such as closing loopholes, dealing with bad actors, and educating consumers. If you want to understand how best to balance innovation and affordability, this book is a must-read.
Developing life-changing drugs is risky and expensive—but that’s not what makes them unaffordable.Drug pricing is a staple of every news cycle and political debate. And while we’ve struggled for decades to agree on solutions that serve all patients without jeopardizing the invention of new medicines, many Americans suffer because they can’t afford the drugs they need.Do we really have to choose between affordability and innovation?In The Great American Drug Deal, scientist and industry expert Peter Kolchinsky answers this question with a decisive No. The pharmaceutical industry’s commitment to creating new lifesaving drugs destined to become inexpensive generics can be balanced…
I am the former president of Pfizer Global Research, where I led research groups around the globe in finding new medicines to treat cancer, addiction, AIDS, immunological diseases, and pain. After retiring from Pfizer, I have been closely involved with biotech companies that also are seeking breakthrough drugs. This industry is a crucial part of the healthcare ecosystem, as evidenced by the remarkable response and, ultimately, the crushing of the COVID-19 pandemic. Yet, it is not just underappreciated but is treated with scorn by many. This booklist provides sources from which the reader can gain a full understanding of the value of the biopharmaceutical industry, the challenges it faces, and its importance to the world’s health.
The COVID-19 pandemic has been burned into the memory of the world. While millions died as a result of this virus, many more would have died if not for the discovery, development, and deployment of the mRNA vaccines. Pfizer CEO Albert Bourla takes you behind the scenes of the race to find this breakthrough vaccine, detailing the risks undertaken, the challenges that were faced, and the crises that were ultimately overcome to save the world.
I found this riveting account inspiring from both a scientific and leadership perspective.
The exclusive, first-hand, behind-the-scenes story of how Pfizer raced to create the first Covid-19 vaccine, told by Pfizer's CEO Dr. Albert Bourla
A riveting, fast-paced, inside look at one of the most incredible private sector achievements in history, Moonshot recounts the intensive nine months in 2020 when the scientists at Pfizer, under the visionary leadership of Dr. Albert Bourla, made "the impossible possible"-creating, testing, and manufacturing a safe and effective Covid-19 vaccine that previously would have taken years to develop.
Dr. Bourla chronicles how the brilliant, dedicated minds at Pfizer, under the enormous strains of the global pandemic, overcame a…
I am the former president of Pfizer Global Research, where I led research groups around the globe in finding new medicines to treat cancer, addiction, AIDS, immunological diseases, and pain. After retiring from Pfizer, I have been closely involved with biotech companies that also are seeking breakthrough drugs. This industry is a crucial part of the healthcare ecosystem, as evidenced by the remarkable response and, ultimately, the crushing of the COVID-19 pandemic. Yet, it is not just underappreciated but is treated with scorn by many. This booklist provides sources from which the reader can gain a full understanding of the value of the biopharmaceutical industry, the challenges it faces, and its importance to the world’s health.
How do you put a price on life? That is a question often asked as healthcare providers seek to determine what is a fair price for a new life-saving drug. European governments have come up with a methodology called QALY (“Quality Adjusted Life Year”), which assigns a monetary value to the quality of life and survival length for patients and then assesses the cost-effectiveness of a drug based upon the drug’s potential to both improve a patient’s quality of life and extend that life.
That sounds pretty reasonable. Actually, it isn’t. This book shows that adopting the QALY methodology in the US would be harmful by limiting patient access to breakthrough medicines as well as discouraging investment into the biotech sector by not rewarding innovation.
While policymakers have often expressed sticker shock at the prices of certain therapies to treat life-threatening illnesses and are right to explore options to lower costs of treatment, one methodology they should reject is the Quality Adjusted Life Year (QALY) standard used in the U.K. and elsewhere. QALY assigns a monetary value to the quality of life and survival-length for patients. QALY has generated controversy, including in the U.K., where its use led to delays in the approval of new cancer treatments already widely available in other countries—and meant the deaths of patients waiting for those potentially lifesaving treatments. In…
I am the former president of Pfizer Global Research, where I led research groups around the globe in finding new medicines to treat cancer, addiction, AIDS, immunological diseases, and pain. After retiring from Pfizer, I have been closely involved with biotech companies that also are seeking breakthrough drugs. This industry is a crucial part of the healthcare ecosystem, as evidenced by the remarkable response and, ultimately, the crushing of the COVID-19 pandemic. Yet, it is not just underappreciated but is treated with scorn by many. This booklist provides sources from which the reader can gain a full understanding of the value of the biopharmaceutical industry, the challenges it faces, and its importance to the world’s health.
There are a lot of critics of the biopharmaceutical industry who belittle the contributions of this industry by accusing it of overselling the value of new medicines, underselling safety, and having numerous conflicts of interest with academic researchers.
This book details the importance of collaborations between doctors and industry for the development of new drugs. For anyone involved in pharmaceutical R&D, it is refreshing to read accounts about successful interactions that lead to breakthroughs.
Rather than look at healthcare as “good guys vs. bad guys,” this book gives great examples of partnerships that result in saving lives.
As a reading educator my mission in life is to give the gift of literacy. Inspiration came from my mother, my first-grade teacher who taught me to read. At 90-plus years old and declining, I dedicated one of my 18 books on teaching literacy to her. She sent me the last letter she would ever write and said, “Oh, oh, oh!”—a quote from Dick and Jane, the book she used to teach reading to three generations of first graders—“I always wanted to write a book but never did. I hope a word of mine is on a page or two of yours.” Her inspiration is on every page.
This book changed my life as a scholar who champions change in how we teach reading.
Susman brilliantly charts the path for anyone who wants to open minds, move hearts, and change the world in any movement or endeavor. She chronicles her own career journey which led her to be the renowned head of corporate affairs at Pfizer during the pandemic and beyond and leaves the reader with a path to follow in their own campaigns for change based on compassion and common sense.
Pfizer's trailblazing communications leader, Sally Susman, reveals how we can break through the noise to get our message across and make positive change.
A global pandemic. A roller-coaster economy. Political tensions ready to ignite, and common civility at an all-time low. For leaders, the pressures and the stakes could not be higher. And in such a stormy, often dangerous world, communications can no longer be considered a soft skill. The ability to reach people and drive public conversation is a rock-hard competency.
In this wise and inspiring book, Sally Susman, the renowned head of corporate…
Vivian Nutton is an emeritus professor of the History of Medicine at UCL and has written extensively on the pre-modern history of medicine. He has lectured around the world and held posts in Cambridge and Moscow as well as the USA. His many books include editions and translations of Galen as well as a major survey of Greek and Roman Medicine, and he is currently writing a history of medicine in the Late Renaissance.
This series of essays by a humane physician-historian who first attracted me to medical history examines basic ideas in medicine across centuries and cultures. Published when the author was almost a hundred, it raises important questions about medical ethics and the place of medicine in society from the Greeks onwards.
Over the course of a career spanning most of the twentieth century, distinguished historian Owsei Temkin has argued passionately for the necessity of chronicling and analyzing the history of medicine. The essays presented in "On Second Thought" and Other Essays in the History of Medicine and Science span Dr. Temkin's career, bringing together new pieces and many previously unavailable outside the journals in which they were originally published. Here the reader will find new thoughts and ideas that deviate from Dr. Temkin's earlier beliefs and reflect a lifetime of research into the historical and ethical foundations of modern medicine. Dr.…
As a reader, I’ve always been attracted to novels that are character-driven, filling my shelves with books about people who seize the day and fight for what they want, who are interesting, relatable, and flawed but who don’t let those flaws define them. As a writer, I like to put my own flawed characters in situations that force them to face who they are and either come to terms with it or overturn themselves and their lives entirely, and all the novels I’ve listed have a hint of this, too. I hope you enjoy them!
I love novels that really spark the imagination and transport you into another world, and this is one of the best I’ve read. The characters are so intricately crafted you feel like you could be them as you’re reading, even though the setting is quite literally thousands of miles away from where you’ll likely be reading it. You truly walk the line between pure wonder and mortal danger in this novel, and you’ll never forget it.
SHORTLISTED FOR THE ORANGE PRIZE FOR FICTION
There were people on the banks of the river.
Among the tangled waterways and giant anacondas of the Brazilian Rio Negro, an enigmatic scientist is developing a drug that could alter the lives of women for ever. Dr Annick Swenson's work is shrouded in mystery; she refuses to report on her progress, especially to her investors, whose patience is fast running out. Anders Eckman, a mild-mannered lab researcher, is sent to investigate.
A curt letter reporting his untimely death is all that returns.
Now Marina Singh, Anders' colleague and once a student of…
I’ve been working with words for over 25 years, as a writer and editor in publishing houses, design studios, and now as a freelance. I help everyone from big brands and small businesses through to academics and consultants get their ideas out of their heads and on to the page. I was an original co-founder of ProCopywriters, the UK alliance for commercial writers. I’ve written and self-published four books, the most recent of which is How to Write Clearly. The books I’ve chosen all helped me to write as clearly as I can—not least when writing about writing itself. I hope they help you too!
Some writing guides can be a little bit “citation needed.” The author certainly sounds like they mean it—but where’s the proof?
There’s no such problem with Anne Janzer’s superb Writing to be Understood. Setting out to get to the heart of what makes a piece of text clear and memorable, she offers a masterclass in clear and expressive writing.
Along the way, she interviews experts in every area from non-fiction writing to psychology, risk management, behavioral design, and even comedy, bringing their authoritative guidance directly into her book. Read, learn, and see your writing improve.
Have you ever wondered what makes your favorite nonfiction books so compelling, understandable, or enjoyable to read? Those works connect with you, as a reader. When you recognize what's happening, you can apply those same methods to your own writing.
Writing To Be Understood is the thinking writer's guide to effective nonfiction writing techniques, such as:
- Using analogies to illustrate unseen concepts - Appealing to the reader's innate curiosity - Balancing humility with credibility
For each topic, the book combines insights from cognitive science with advice from writers and expert practitioners in fields of psychology, technology, economics, medicine, policy,…
Apart from my professional expertise as a philosopher, I have directly observed science by working as a professional researcher in Physics and Astronomy. In any field, either arts, science, humanities, literature,... I observe the same thing: decline, ugliness, lack of spirit, lack of great intellectual achievements, and stupidity. Of course, we have technology, medicine, engineering, the Internet, and material things… and they are better than ever, but our culture and spirit are dying. Science is part of this culture, which is also in decadence, and working as a scientist and reading Spengler is a good combination to realize it.
In my opinion, Horgan’s book is of great value, and I find it an important reference in considering the subject of “the end of science.”
This book is brave and lucid, with plenty of good ideas on topics related to the limits of knowledge in science. The intuition that the scientific age is declining is prophetic, I guess, but not so the causes Horgan gives. It is possible the limits of knowledge is one of the causes, but there is much more behind the twilight of science, and I think it is more related to being sated with knowledge rather than to the limits of knowledge.
It is more a sociological/anthropological question than a pure debate about whether there remain scientific problems to be solved.
In The End of Science, John Horgan makes the case that the era of truly profound scientific revelations about the universe and our place in it is over. Interviewing scientific luminaries such as Stephen Hawking, Francis Crick, and Richard Dawkins, he demonstrates that all the big questions that can be answered have been answered, as science bumps up against fundamental limits. The world cannot give us a "theory of everything," and modern endeavors such as string theory are "ironic" and "theological" in nature, not scientific, because they are impossible to confirm. Horgan's argument was controversial in 1996, and it remains…
In Denmark, I teach at the Center for Videnskabsstudier.“Videnskabsstudier” is often translated as Science Studies.It thus connotes a rather broad field, which includes philosophical, historical, and sociological studies of science.And the notion of “videnskab”, which is frequently translated as science is interpreted rather broadly, to include, in addition to the natural science, the social sciences, and the humanities, indeed, basically any field one might study at a university. In fact, my own research intersects with and is influenced by research in all these fields.
Zuckerman provides a comprehensive study of the American scientists who won Nobel prizes between 1907 and 1972.
The book provides a window into the personalities of the people doing Nobel prize-winning research, as well as the sort of environments in which they were socialized and educated. Nobel laureates have tended to study and work with other Laureates or future Laureates. She also discusses the impact that winning a Nobel prize has on scientists, and the effects of the prize are not wholly positive.
The book also demonstrates the potential power of sociological analyses. Zuckerman creatively combines interview data with quantitative analyses. I think Zuckerman’s books are a fantastic example of how to conduct empirical research in sociology and the social sciences more generally.
Scientific Elite is about Nobel prize winners and the well-defined stratification system in twentieth-century science. It tracks the careers of all American laureates who won prizes from 1907 until 1972, examining the complex interplay of merit and privilege at each stage of their scientific lives and the creation of the ultra-elite in science.
The study draws on biographical and bibliographical data on laureates who did their prize-winning research in the United States, and on detailed interviews with forty-one of the fifty-six laureates living in the United States at the time the study was done. Zuckerman finds laureates being successively advantaged…
